Skip to main content

Advertisement

Table 2 Characteristics of the chronic liver disease patients with malignancies:

From: Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease

A. Patients with hepatocellular carcinoma (HCC)
Pat # diagnosis LDH (U/l) [80-240] CRP (mg/l) [<5] WBC (G/l) [4.3-10] AFP (μg/l) [<15] CEA (μg/l) [<5] CA19-9 (kU/l) [<37] YB-1/p18
9 primary 111 5 7.2 623 ++ 2 2 pos. ++
15 HCV 525 ++ 17 ++ 4.1 4 2 276 ++ neg.
16 HCV 230 5 6.2 1023 ++ 1 10 neg.
17 HCV 162 5 2.8 87 ++ 2 59 ++ neg.
27 primary 179 5 6.6 12598 ++ 4 49 ++ neg.
38 HCV 211 5 5.1 9 3 36 neg.
49 HCV 254 ++ 5 3.7 6 3 100 ++ neg.
51 primary 136 5 4.1 4 1 17 neg.
59 alcohol 194 9 ++ 5.3 1 1 16 pos. ++
66 alcohol 182 5 3.8 155 ++ 3 50 ++ neg.
74 HCV 187 5 4.0 15 2 30 neg.
76 alcohol 235 11 ++ 4.3 208 ++ 1 14 neg.
86 HCV 184 5 3.4 6 1 34 pos. ++
88 unknown 175 7 ++ 7.2 4 2 16 neg.
107 HCV 548 ++ 5 5.7 10 1 28 neg.
B. Patients with malignancies other than HCC
Pat # diagnosis LDH (U/l) [80-240] CRP (mg/l) [<5] WBC (G/l) [4.3-10] AFP (μg/l) [<15] CEA (μg/l) [<5] CA19-9 (kU/l) [<37] YB-1/p18
41 PNET 288 ++ 31 ++ 9.7 5 1 363 ++ neg.
50 PNET 121 5 7.2 5 1 8 pos. ++
53 CCC 206 7 ++ 5.8 9 4 177 ++ pos. ++
77 PNET 97 6 ++ 4.4 3 1 84 ++ pos. ++
90 NHL * 234 5 2.7 40 ++ 4 257 ++ neg.
  1. HCV, Hepatitis C virus infection; PNET, pancreatic neuroendocrine tumor; CCC, cholangiocellular carcinoma; NHL, non-hodgkin lymphoma.
  2. *Patient received prior curative radiotherapy.